A Virtual Reality View – Optimizing Immuno-Oncology Therapy Through the Management of Immune-Related Adverse Events: The Role of the Emergency Physician
Arjun Balar, MD
Assistant Professor, Department of Medicine
Director, Genitourinary Medical Oncology Program
NYU Langone Medical Center
New York, NY
This case-based enduring activity will cover the long-term treatment and management of patients with adverse events related to cancer immunotherapy.
This activity is intended to meet the educational needs of Emergency Department physicians and other Emergency Room healthcare professionals working as part of the multidisciplinary care team.
After completing the CME activity, learners should be better able to:
- Discuss tumor immunosurveillance and immune escape in the pathophysiology of adult malignancies;
- Review the clinical trial data for approved immune checkpoint-inhibitors, with a focus on the treated malignancies and their associated immune-related adverse events (irAEs);
- Describe the diagnosis of irAEs associated with immunotherapies and current recommendations for their management and monitoring;
- Examine the continuum of oncology care provided in the emergency room setting through the identification and management of irAEs.
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
This CME activity was planned and produced in accordance with the ACCME Essentials.
CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 1.5 AMA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSING CREDIT INFORMATION
Purpose: This program would be beneficial for nurses involved in the care of patients with cancer who are treated or eligible for treatment with immunotherapy. Credits: 1.5 ANCC Contact Hour(s)
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.5 contact hour(s) of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME)
Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Dr Balar has received consultant fees from Merck, Genentech, AstraZeneca, and Pfizer; fees for Non-CME/CE Services received directly from a commercial interest or its agent from Merck, Genentech, and AstraZeneca.
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose.
The staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CNE activity:
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Flavia Piazza, PhD, Medical and Scientific Services for Med Learning Group has nothing to disclose.
Chris Drury, MA, MS, Medical and Scientific Services for Med Learning Group has nothing to disclose.
Lisa Dorin, Sr. Program Manager for Med Learning Group, has nothing to disclose.
Lauren Welch, MA, VP of Accreditation and Outcomes for Med Learning Group has nothing to disclose.
Brianna Hanson of Accreditation and Outcomes for Med Learning Group has nothing to disclose.
Brooke Hefele of Accreditation and Outcomes for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures;
2. Participate in the enduring activity; and
3. Complete pre-and-post surveys and evaluation.
You will receive your certificate as a downloadable file.
Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact: Med Learning Group at email@example.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/
RELEASE DATE: October 12, 2018
EXPIRATION DATE: October 12, 2019
Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.